U.S., Nov. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07249528) titled 'A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy' on Nov. 18.
Brief Summary: The purpose of this study is to collect voice recordings and nervous system (neurologic) assessments from people with non-Hodgkin lymphoma (NHL) or multiple myeloma (MM) who are receiving standard treatment with CAR T-cell therapy. Researchers will study whether these voice recordings and assessments are a practical (feasible) way to monitor for immune effector cell-associated neurotoxicity syndrome (ICANS). Feasibility will be measured by tracking how many participants join the study and complete the assessments....